Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IHL-42X in Obstructive Sleep Apnea
NCT07635563Phase 2Recruiting
- Sponsor
- Incannex Healthcare
- Start
- Jul 2026
- Primary completion
- Apr 2027
- Countries
- 1
01
Overview
A Phase 2 trial of IHL-42X in obstructive sleep apnea (OSA), sponsored by Incannex Healthcare. Started Jul 2026; status: recruiting.
02
Drugs
IHL-42X
03
Conditions
obstructive sleep apnea (OSA)
Beyond the preview
Go deeper on NCT07635563.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07635563.